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Abstract 
We measured calcium-dependent phospholipase A 2 (PLA 2) activity and immunoreactive group II PLA 2 levels of 54 normal discs 
obtained from cadavers and 73 disc samples surgically obtained from patients with spinal disorders, including intervertebral disc 
herniations, spondylosis, and spondylolisthesis. Both cadaveric and surgical disc specimens contained about two-fold greater PLA 2 
activity than the ileal mucosa, one of the richest sources of group II PLA 2. Discs of middle-aged cases had significantly higher activity 
than those of younger and elder cases. In cadaveric normal discs, calcium-dependent PLA 2 activity was significantly higher in females 
than in males. Annulus fibrosus and nucleus pulposus contained the same PLA 2 levels. In diseased iscs, herniated fragments that had 
extruded or protruded out of the discs possessed lower activity than other parts of discs in the intervertebral space. Immunoreactive group 
II PLA 2 levels of intervertebral discs closely correlated with PLA 2 enzymatic activity. We purified a PLA 2 from human intervertebral 
disc to homogeneity o further identify the isozymic nature of discal PLA 2. Its NH 2-terminal amino acid sequence and molecular weight 
were identical to those of human group II PLA 2. Immunohistochemical analysis using a monoclonal nti-group II PLA 2 antibody showed 
that in both annulus fibrosus and nucleus pulposus chondrocytes contained intense group II PLA 2 immunoreactivity n their cytoplasm, 
and that the matrix contained no substantial immunoreactivity. These results suggest that group II PLA 2 in chondrocytes has important 
physiological roles in discal ordinary metabolism, maintaining discal homeostasis. 
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1. Introduction 
Phospholipase A 2 (PLA 2) hydrolyzes the sn-2 fatty 
acyl ester bond of glycerophospholipids to produce free 
fatty acids and lysophospholipids. This enzyme plays im- 
portant roles in remodeling membrane phospholipids, in 
regulating icosanoid biosynthesis, and in mediating inflam- 
matory reactions [1,2]. 
Abbreviations: PLA2, phospholipase A2; IR-group II PLA,, 
immunoreactive group II phospholipase A2; POPG, l-palmitoyl-2- 
oleoyl-sn-glycero-3-phosphoglycerol; HPLC, high-performance liquid 
chromatography; ADAM, 9-anthryldiazomethane; SDS, Sodium dodecyl 
sulfate: JOA score, an evaluation score proposed by the Japanese Or- 
thopaedic Association for spinal lesions; OPLL, ossification of posterior 
longitudinal ligament of cervical spine 
* Corresponding author. Fax: +81 775 48 2254; Tel: +81 775 48 
2252: e-mail: miyahara@belle'shiga-med'acdp 
Recent findings of high levels of PLA_, activity in 
herniated nucleus pulposus uggested that PLA 2 within the 
nucleus pulposus can cause nerve injury and that activation 
of PLA 2 within the intervertebral disc contributes to the 
process of disc degeneration [3]. However, the precise 
roles played by PLA 2 in the pathogenesis of disc hernia- 
tion remain to be clarified, because the properties and the 
origin of PLA 2 within the discs normal and diseased are 
unknown. 
In this study we purified a PLA~ from human interver- 
tebral discs to homogeneity and confirmed that its N-termi- 
nal amino acid sequence was identical to human group II 
PLA2. The location of group II PLA 2 in discs was im- 
munohistochemically determined with specific monoclonal 
antibodies raised against human group II PLA 2. We mea- 
sured PLA 2 activity and immunoreactive group II PLA 2 
(IR-group II PLA 2) levels of uninflamed intervertebral 
disc samples obtained from normal fresh cadavers and 
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from patients with a variety of spinal disorders. We further 
compared PLA 2 levels of disc portions remaining in the 
original disc space with those of extrudedly and protrud- 
edly herniated portions of discs. 
2. Materials and methods 
2.1. Disc materials 
Human intervertebral discs (n = 73) were obtained from 
45 patients, 26 females and 19 males, aged 12-80 years 
(mean 41.4), who underwent discectomy from the anterior 
or posterior approach (Table 1). Erythrocyte sedimentation 
rates, serum C-reactive protein concentration, and leuko- 
cyte counts of the patients were normal. Severity of clini- 
cal symptoms was assessed using respective valuation 
scores for cervical and lumbar lesions proposed by the 
Japanese Orthopaedic Association (JOA score). To assess 
disc degeneration, magnetic resonance imaging (MRI) 
findings of the patients were evaluated using the grading 
scale of Eyre et al. [4]. After surgical removal, disc 
samples were immediately frozen and stored at -80°C. 
Since it is ethically impossible to obtain normal disc 
samples from patients and healthy subjects, intervertebral 
discs (n = 54) were obtained from 10 fresh human cadav- 
ers, aged 19-73 years (mean 46.2), which had been dis- 
sected at the Osaka Medical Examiner's Office. None of 
the deceased had an obvious history of spinal disorders 
and autopsy confirmed that they had not suffered from any 
inflammatory disorders. A portion of each disc was fixed 
in formalin and stained with hematoxylin-eosin a d tolui- 
dine blue. All of the discs were histologically normal with 
some age-dependent changes [5]. The results of prelimi- 
nary experiments showed that incubation of cadaveric disc 
homogenates did not affect PLA 2 activity for at least 8 h. 
Hence, we used cadaveric discs as control specimens. 
Annuli and nuclei of C6/7, L1 /2  and L4/5 interval discs 
were removed and stored at -80°C. 
2.2. Assay for PLA 2 actiei~ 
Each disc sample (40-80 mg) was thawed at room 
temperature and then homogenized in 40 vol. of 25 mM 
Hepes-HCl buffer (pH 7.4) on ice with a glass homoge- 
nizer. An equal volume of 2 M KBr was added to the 
homogenate. After 30-min incubation at 4°C under contin- 
uous stirring, the mixture was centrifuged at 15 000 X g 
for 10 min at 4°C. An aliquot of the supernatant (2 ixl) was 
used for the assay. PLA 2 activity was determined as 
reported previously [6,7]. Briefly, the assay mixture (50 
Ixl) contained 0.8 mM 1-palmitoyl-2-oleoyl-sn-glycero-3- 
phosphoglycerol (POPG, Avanti Polar Lipids), 5 mM 
cholate, 0.1 M Tris-HC1 (pH 8.5), 0.1 M NaC1, 5 mM 
CaC12, and the enzyme. The reaction was stopped by 
adding 200 Ixl of the Dole's reagent, and then fatty acids 
were extracted by the method of Dole and Meinertz [8]. 
Heptadecanoic a id (5 nmol) (Nacalai Tesque, Kyoto) was 
used as an internal standard. Extracted fatty acids were 
labeled with 9-anthryldiazomethane (Funakoshi Co., 
Tokyo), and then each of the derivatized fatty acids was 
quantitated by reverse-phase high-performance liquid chro- 
matography (HPLC) with UV detection at 254 nm. Cal- 
cium-dependent PLA 2 activity was estimated as the differ- 
ence between the activity assayed in the presence of 5 mM 
CaCI 2 and that in the presence of 10 mM EDTA. Protein 
concentrations were determined with bicinchoninic acid 
protein assay reagent (Pierce). 
2.3. Assay for immunoreactive group H PLA 2 
IR-group II PLA 2 in the KBr extracts from interverte- 
bral discs was measured by a sensitive radioimmunoassay 
kit specific to human group II PLA 2, using a monoclonal 
antibody against human splenic group II PLA 2 (donated 
by the Diagnostic Science Department, Shionogi and Co., 
Settsu, Osaka) [9]. 
2.4. Purification of PLA: from human intervertebral discs 
Table 1 
Intervertebral disc samples obtained from patients with various spinal 
disorders 
Spinal disorders Number Mean age Number 
of cases (range) of discs a 
Intervertebral disc herniation 28 39 (13-70) 37 
Spondylosis 5 53 (35-80) 12 
Spondylolisthesis 4 51 (45-59) 5 
Idiopathic scoliosis 2 12, 16 7 
OPLL b 2 44, 75 5 
Traumatic fracture/dislocation 2 21, 23 3 
Neurenteric cyst 1 48 3 
Metastatic spinal tumor 1 59 1 
Total number 45 73 
a In several cases, more than two disc samples were obtained from one 
patient. 
b Ossification of posterior longitudinal igament of cervical spine. 
Human intervertebral disc (5.4 g wet wt.) was cut into 
thin slices and then homogenized in 70 ml of 10 mM 
Tris-HCl (pH 7.4) with a glass homogenizer. After 20 min 
of incubation on ice under continuous tirring, the ho- 
mogenate was centrifuged at 20 800 × g for 20 min at 4°C. 
The pellet was homogenized in 70 ml of 10 mM Tris-HCl 
(pH 7.4) containing 1 M KBr and kept on ice under 
continuous tirring for 30 min to extract PLA~ activity. 
The homogenate was centrifuged at 20 800 × g for 20 min 
at 4°C. The supernatant (KBr extract) was diluted 10-fold 
with 10 mM Tris-HC1 (pH 7.4), and applied to a SP 
Sepharose column (4 x 3 cm, Pharmacia Biotech) pre- 
equilibrated with the same buffer. The column was washed 
with 150 ml of 10 mM Tris-HC! (pH 7.4) containing 0.15 
M NaC1, and then PLA 2 activity was eluted with 10 mM 
Tris-HCl (pH 7.4) containing 1 M NaCI and 0.1% Triton 
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X-100. The eluent (SP Sepharose-1) was diluted 10-fold 
with 10 mM Tris-HC1 (pH 7.4) and applied again to a SP 
Sepharose column (2 x 1.5 cm) pre-equilibrated with 10 
mM Tris-HC1 (pH 7.4) containing 0.1% Triton X-100. 
After the column was washed with the same buffer, PLA 2 
activity was eluted with 10 mM Tris-HC1 (pH 7.4) contain- 
ing 1 M NaCI and 0.1% Triton X-100. The eluent was 
further concentrated to about 1.8 ml with a Microcon 30 
microconcentrator (Amicon). Aliquots (100-200 Ixl) of the 
concentrated PLA 2 solution were repeatedly (15 times) 
injected to a TSK gel G2000SWxL (7.8 X 150 mm, Tosoh) 
pre-equilibrated with 10 mM Tris-HC1 (pH 7.4) containing 
0.3 M NaC1 and 0.1% Triton X-100. Elution was per- 
formed with the same buffer at a flow rate of 0.5 ml/min. 
The absorbance at 295 nm was continuously monitored. 
The pooled PLA2-active fractions (Gel filtration) were 
concentrated using an SP Sepharose column (1 × 1 cm), as 
described above. The resultant solution (20 ml, SP 
Sepharose-2) was subjected to a Cosmosil 5C4-300 col- 
umn (4.6 × 50 ram, Nacalai Tesque) pre-equilibrated with 
0.1% trifluoroacetic acid (TFA) in water. The column 
temperature was maintained at 20°C. Elution was per- 
formed with the linear gradient of acetonitrile in 0.1% 
TFA: 0-25% in 5 min, 25-35% in 40 min, and then 
35-100% in 5 min at the flow rate of 0.3 ml/min. 
2.5. Polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate (SDS)-polyacrylamide g l elec- 
trophoresis (PAGE) was performed on a 15% gel accord- 
ing to the method of Laemmli [10]. Proteins were stained 
with 0.25% Coomassie Brilliant Blue R-250 in 45% 
methanol-9% acetic acid. The marker proteins were pur- 
chased from Boehringer Mannheim. 
2.6. NH2-terminal amino acid sequence and molecular 
weight determination 
NH2-terminal amino acid sequence analysis was per- 
formed by an Applied Biosystem 473A and a 120A PTH 
analyzer. Matrix-assisted laser desorption mass spectra 
were obtained on a Shimadzu/Kratos laser ionization 
time-of-flight (TOF) mass spectrometer (KOMPACT 
MALDI III). a-Cyano-4-hydroxycinnamic acid was used 
as a matrix-forming material and myoglobin was used for 
mass calibration. 
2.7. Immunohistochemistry 
Formalin-fixed and paraffin-embedded sections of disc 
specimens that were obtained at autopsy and surgery were 
reacted with mouse monoclonal anti-group II PLA 2 anti- 
body. The primary immunoreaction was visualized using 
an ABC kit (Vector Laboratories, Burlingame, CA, USA) 
according to the manufacturer's instructions [11]. For con- 
trol, the primary antiserum was omitted or was replaced by 
anti-group I (pancreatic) PLA2 antibody. Cartilage of the 
femoral condyle from a 59-yr-old female suffering from 
rheumatoid arthritis was also examined to compare stain- 
ability of articular cartilage with that of disc cartilage. 
2.8. Statistical analysis 
Data were expressed as mean ___ standard deviation 
(S.D.). Data of PLA 2 activity and IR-group II PLA 2 levels 
were analyzed by Mann-Whitney test. Regression analysis 
was used to determine the relationships between PLA 2 
activity and IR-group II PLA 2 levels, MRI grades or JOA 
scores. Results of P < 0.05 were considered significant. 
3. Results 
3.1. Characterization of PLA 2 purified from human inter- 
certebral discs 
With minor modifications of the HPLC method [6,7,12], 
a PLA 2 (14 mg) was purified to homogeneity from human 
intervertebral discs (5.4 g wet wt.) with the overall recov- 
ery of 7.7% and about 150-fold purification (Table 2). At 
each chromatographic step during purification, PLA 2 ac- 
tivity was eluted as a single peak (data not shown). The 
specific activity of 420 i~mol/min per mg was obtained 
with the mixed micelles of POPG and cholate as the 
substrate, and is similar to that of group II PLA 2 purified 
from human ileal mucosa [12]. The purified enzyme mi- 
grated as a single band with an apparent molecular mass of 
14.9 kDa on SDS-polyacrylamide g l (data not shown). 
The molecular mass was determined to be 13 888 Da by 
mass spectrometry. The sequence of the NH2-terminal 25 
residues of human intervertebral disc PLA 2 was deter- 
mined to be NLVNFHRMIKLTTGKEAALSYGFYG and 
Table 2 
Purification of PLA 2 from human intervertebral disc 
Step Total vol. Total protein Total act. 
(ml) (mg) (p~mol/min) 
Specific act. (p, mol/min Yields Purification 
per mg protein) (%) (-fold) 
KBr extract 74.0 26.3 75.5 2.87 100 1 
SP Sepharose- 1 50.0 6.0 72.5 12.1 96 4.2 
Gel filtration 11.0 0.572 24.9 43.5 33 15.2 
SP Sepharose-2 2.0 0.394 17.4 44.2 23 15.4 
HPLC 0.12 0.014 5.8 420 7.7 146 
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identical to that of human group II PLA: purified from 
spleen [13]. 
3.2. PLA 2 activity and immunoreactive group II PLA 2 
levels in intervertebral discs 
Table 1 summerizes 73 disc samples obtained from 
patients with spinal disorders. The disc samples (n = 19) 
obtained from patients with idiopathic scoliosis, OPLL, 
trauma, neurenteric cyst, and metastatic tumor were appar- 
ently normal. 
All examined iscs contained PLA 2 activity and IR- 
group II PLA 2 levels greater than those of other human 
group II PLA2-rich organs, e.g., the ileum mucosa (51 
nmol /min/mg protein) [14] (Fig. 1). Discal PLA: activity 
correlated with IR-group II PLA 2 levels (r  = 0.887, P < 
0.0001). 
PLA 2 activity in surgical and cadaveric specimens were 
87.3 _+ 68.3 nmol /min/mg protein (n = 73) and 101 _+ 71 
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Fig. 1. PLA 2 activity (A) and IR-group II PLA 2 levels (B) in various 
disc conditions. Discs were obtained from patients with a variety of spinal 
diseases indicated in Table 1 (n = 73) and from cadavers without spinal 
and inflammatory disorders (n = 54). Discs obtained from patients with 
scoliosis, OPLL, trauma, neurenteric cyst and metastatic tumor showed 
apparently normal appearance. *, P < 0.01; * * P < 0.05, compared 
with normal cadaveric discs. 
3 
e- 
°~.o 2 
× 
0 
B 
I 
~ 4.5  
o 
A ~ ~ 
I I A I  I 
a 
A 
A A 
AA 
. o 
A a A 0 
,,. ~ A o% 
A A ~ o o 
IL A ,, ,, ~,,, .8o °0 
r - - l  t i 
: 
a 
a. ,", 3 .0  , ,, : , : :  o 
• A ~ A 
0 ' ~;¶"  ~,'~'" ~, : ~, 
0 20 40 60 80 
Age 
Fig. 2. Age-dependence of PLA 2 activity (A) and IR-group II PLA 2 
levels (B). Patients and cadavers were divided into three groups according 
to age: O, aged 12-29 yr; A, aged 30-59 yr; o, >60 yr old. *: 
P < 0.0002, **: P < 0.03, ***:  P <0.002. 
nmol/min/mg protein (n = 54), respectively; and IR- 
group II PLA 2 levels in surgical and cadaveric specimens 
were 878 _+ 908 ng/mg protein and 1005 _+ 857 ng/mg 
protein, respectively. In both PLA 2 activity and IR-group 
II PLA 2 levels, there was no significant difference be- 
tween discs obtained from patients and those from cadav- 
ers. 
As shown in Fig. 2, discs of the middle-aged (30-59 
years old, 110 + 70 nmol/min per mg protein) had signifi- 
candy higher activity than those of the second and third 
decades (12-29 years old, 60.3 ___ 55.0 nmol/min per mg 
protein, P < 0.0002) and those of elders (>__ 60 years old, 
70.3_ 49.2 nmol/min per mg protein, P < 0.03). Simi- 
larly, discal IR-group II PLA 2 levels in the middle-aged 
(1153 +981 ng/mg protein) were significantly greater 
than those of the second and third decades (570 + 564 
ng/mg protein, P < 0.002) and those of elders (513 ___ 386 
ng/mg protein, P < 0.002). 
In cadaveric normal discs, PLA 2 activity (P  < 0.04) 
and IR-group II PLA 2 levels (P  < 0.04) were significantly 
higher in females (118 + 78 nmol/min/mg protein, and 
1255 _+ 987 ng/mg protein, respectively) than in males 
(76.7-t-52.4 nmol/min per mg protein, and 637-t-429 
ng/mg protein, respectively) (Fig. 3). Ages of female 
group (19-72) matched those of male groups (24-73). No 
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Fig. 3. Sexual disparity of PLA 2 activity (o) and IR-group II PLA 2 
levels (0 )  in all cadaveric normal discs. (P < 0.04). 
significant differences were found between PLA 2 activi- 
ties in annulus fibrosus (109.8 + 81.7 nmol/min per mg 
protein) and those in nucleus pulposus (92.3_ 58.5 
nmol/min per mg protein) (Fig. 4). The PLA 2 activity in 
intervertebral disc had no correlation with spinal levels. 
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Fig. 4. PLA 2 activity (A) and IR-group II PLA 2 levels (B) in various 
disc samples. 4 portion of annulus fibrosus of surgical specimens other 
than herniated isc fragments, b,portion of nucleus pulposus of them. *, 
P < 0.05. 
3.3. PLA: activity and immunoreactive group H PLA: 
levels in diseased iscs 
In surgical specimens, the PLA 2 activity and IR-group 
II PLA 2 levels tended to be higher in females than in 
males, as recognized in cadaveric specimens, but there was 
no statistical significance. Both PLA 2 activity and IR-group 
II PLA 2 levels did not correlate with degenerative grades 
of MRI findings of discs or with the clinical severity as 
assessed by JOA scores (data not shown). Both extruded 
and protruded portions of herniated iscs [15] had lower 
PLA 2 activity (P < 0.05) and IR-group 11 PLA 2 levels 
(P  < 0.05) than the disc materials that remained at their 
original site. Ages of patients with disc herniations matched 
those of patients with other spinal disorders, and those of 
cadavers (Fig. 4). 
Of all discs examined, thoracic disc materials urgically 
obtained from two patients with idiopathic scoliosis, aged 
12 and 16, had significantly low PLA 2 activity and IR- 
group II PLA 2 levels (P < 0.01). On the contrary, cervical 
disc materials obtained from a 48-year-old female suffer- 
ing from a neurenteric cyst in the spinal canal had signifi- 
cantly high activity and IR-group II PLA 2 levels (P  < 
0.05) (Fig. 1). 
3.4. Immunohistochemistry 
All of the chondrocytes xamined in both annulus fibro- 
sus and nucleus pulposus exhibit group II PLA 2 immuno- 
reactivity in their cytoplasm (Fig. 5). Unlike articular 
chondrocytes (Fig. 6), the chondrocyte lacunae and the 
matrix of discs had no IR-group II PLA 2- Control sections 
using anti-group I (pancreatic) PLA 2 antibody were not 
stained at all. 
The staining patterns of articular cartilage differ from 
those of disc cartilage. There was a large amount of 
IR-group II PLA 2 in the deep layer adjacent o subchon- 
dral bone, while there was its small amount in the superfi- 
cial layer near the joint space. In agreement with previous 
results [16], the chondrocyte lacunae and surrounding carti- 
lage matrix, as well as the cytoplasm of the chondrocytes, 
contained IR-group II PLA 2 (Fig. 6). 
4. D iscuss ion  
In this study we found high PLA 2 activity and IR-group 
II PLA 2 levels in all intervertebral discs obtained from 
patients with disc herniations and other spinal disorders, 
and normal discs obtained from cadavers. Mean enzymatic 
activity and IR-group II PLA 2 levels per the protein 
concentration i  the intervertebral discs were greater than 
that found in normal terminal ileal mucosa, one of the 
richest source of group IT PLA 2. In comparison with 
activity in various rat tissues assayed by the same method, 
human intervertebral discs showed a level of activity as 
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high as in rat pancreas or spleen [7]. Mean IR-group II 
PLA~ levels was 25 times higher than those of inflamed 
colonic mucosa of patients with Crohn's disease and ulcer- 
ative colitis [14]. It is surprising that normal intervertebral 
discs with sparse cellularity showed higher IR-group II 
PLA 2 levels than inflamed mucosa having much higher 
cellularity. Since the discs contain abundant extracellular 
proteins and have greater protein contents than colonic and 
ileal mucosas, the amount of group II PLA 2 per a cell in 
the discs is much greater than those of intestinal mucosal 
cells. 
We purified a PLA 2 with a molecular mass of 13 888 
Da from human intervertebral discs, and the sequence of 
its NH2-terminal 25 amino acid residues was identical to 
that of human group II PLA 2 purified from spleen [13]. At 
all the chromatographic steps during purification, PLA~ 
activity was eluted as a single peak. The discal PLA,  
activity closely correlated with IR-group II PLA 2 levels. 
These results indicate that group II PLA 2 is responsible 
for measurable calcium-dependent PLA 2 activity in inter- 
vertebral discs. 
IR-group II PLA 2 was localized in the cytoplasm of 
chondrocytes in both annulus fibrosus and nucleus pulpo- 
sus. All chondrocytes in discs were uniformly stained and 
the chondrocyte lacunae and disc matrix had no group II 
PLA 2 immunoreactivity. These results suggest that the 
PLA~ is stored in and secreted from chondrocytes in 
response to stimulations. 
Recently articular cartilage .was found to contain large 
quantities o f  group II PLA 2 in both osteoarthritis and 
rheumatoid arthritis [16-21]. A previous immunohisto- 
chemical study [16] showed that in articular, laryngeal and 
auricular cartilage the peripheral areas of the chondrocyte 
lacunae and surrounding cartilage matrix contain IR-group 
II PLA 2 and that there were two distinct populations of 
PLA2-containing and PLAo-deficient chondrocytes. We 
confirmed these findings in this study, and demonstrated 
that the localization of group II PLA 2 in intervertebral 
discs and the articular cartilage is quite different. This may 
be interpreted that chondrocytes in the disc store the 
enzyme in the secretary granule, like intestinal Paneth cells 
(Tojo et al. unpublished results), whereas chondrocytes in
the articular cartilage are continuously releasing the en- 
zyme into the extracellular matrix after its synthesis. 
Chondrocytes in the deep layer of articular cartilage 
adjacent to subchondral bone had a larger amount of 
IR-group II PLA 2 than in the superficial layer near the 
joint space. These results coincide with the fact that deep 
layers of articular cartilage show higher PLA 2 activity 
than superficial ones in rheumatoid arthritis and os- 
teoarthritis [19], and that cultured chondrocytes obtained 
from the deep layers of the cartilage released more PLA 2 
than those obtained from the superficial ayers [20]. 
Discs of middle-aged patients and cadavers had signifi- 
cantly high PLA 2 activity and IR-group I1 PLA_~ levels as 
compared with those of younger and elder cases. For 
instance, discs of two young girls with idiopathic scoliosis 
had significantly low PLA 2 activity and IR-group II PLA 2 
levels, while discs of a midd.le-aged patient with neurenteric 
cyst had significantly high PLA 2 activity and IR-group II 
PLA~ levels. Since the histological appearance and MRI 
findings of these cases were normal, the measured iffer- 
ence in the activity and IR-group II PLA 2 levels may be 
due to physiological age-dependent changes in expression 
levels of the enzyme. In this context, Recklies and White 
reported that PLA 2 activity was not detectable in cartilage 
from newborns [21]. These findings suggest hat group II 
PLA 2 develops postneonatally, that is, its amounts in discs 
gradually increase during adolescence, reach the peak of 
synthesis at middle age, and then decrease with aging. A 
decrease in the number of viable chondrocytes in senescent 
discs [5] may cause reduction of PLA~ activity. An im- 
munohistochemical study [22], however, suggests that the 
fetal gastric mucosa contained a large amount of IR-group 
II PLA 2, but not the adult mucosa. 
Cadaveric discs of females had higher PLA 2 activity 
and IR-group II PLA 2 levels than those of males, although 
serum IR-group II PLA, levels did not depend on sex (H. 
Tojo, unpublished results). It remains to be clarified 
whether or not the expression of group II PLA~ in inter- 
vertebral discs is hormonally regulated. 
The nucleus pulposus consists of gel-like materials that 
are rich in proteoglycans, whereas the annulus fibrosus is 
mainly composed of collagen fibers. Since there was no 
difference in the PLA 2 activity and IR-group II PLAo 
levels between nucleus pulposus and annulus fibrosus, the 
difference in local environments of cartilage matrix may 
not affect the degree of expression of group II PLA 2 in the 
chondrocytes. 
Herniated disc fragments had lower PLA~ activity and 
IR-group II PLA~ levels than disc materials remaining 
within the site. When a disc fragment has herniated out of 
Fig. 5. Immunohistochemical loc lization of group It PLA 2 in the intervertebral disc in normal cadaveric ntervertebral disc of a fenmle aged 47, using 
anti-human group II PLA~ monoclonal ntibody. A. Despite sparse, cellularity, all of the chondrocytes were intensely stained with the antibody. B. High 
power magnification f the part indicated by an arrow in A. The cytoplasm ofdisc chondrocytes contained IR-group II PLA ~. The chondrocyte lacunae 
and the matrix of discs had no immanoreactive PLA,. 
Fig. 6. Staining.in a femoral condyle of a female aged 59 suffering from rheumatoid arthritis, using anti-human group It PLA ~ monoclonal ntibody. 
Articular cartilage showed varying degrees of stainability o the group II PLA_~ antibody. The chondrocyte lact]nae and surrounding cartilage matrix, as 
well as the cytoplasm of the chondrocytes, contained IR-group II PLA 2. There was a marked amount of IR-group II PLA~ in the deep layer adjacent to 
subchondral bone (top), while there was its small amount in the superficial layer near the joint space (bottom). 
190 K.-i. Miyahara et al. / Biochimica et Biophysica Acta 1316 (1996) 183-190 
its original site, the ordinary nutritional pathway of chon- 
drocytes may be obstructed, leading to decreasing produc- 
tion of PLA 2. This result is compatible with the fact that 
the amounts of prostaglandin released from sequestrated 
discs as measured by radioimmunoassay, were very low, 
compared with those from lumbar facet cartilage and bone 
[23]. Alternatively, there is a possibility that certain stimuli 
in herniated iscs increase the secretion of group II PLA: ,  
leading to depleting the enzyme store. 
Prostaglandins and leukotrienes timulate neural ele- 
ments and cause pain [24,25], and, in addition, activation 
of PLA 2 produces mechanical hyperalgesia [26]. Thus, 
PLA 2 activity in discs seems to affect the severity of 
symptoms. However, in this study, the activity did not 
correlate with clinical features of patients assessed by JOA 
scores. The PEA 2 activity measured by the present method 
may not reflect PLA 2 activity around nerves in the vicinity 
of herniated iscs, or it may be unrelated to icosanoid 
production. Since herniated iscs contain low levels of 
PLA 2 and prostaglandins, immunologic reactions might be 
more responsible for pathophysiology of radiculopathy 
[23]. 
PLA 2 liberates arachidonic acid from membrane phos- 
pholipids at the site of inflammation, and extracellular 
group II PLA 2 expression has been linked to the potentia- 
tion and perpetuation of inflammatory eactions [27]. How- 
ever, because morphologically normal cadaveric discs had 
the same group II PLA 2 levels and activity as surgical 
specimens, we conclude that group II PLA 2 is constitu- 
tively produced and plays important physiological roles in 
discal ordinary metabolism to maintain cartilage homeosta- 
sis. In the metabolism of chondrocytes, prostaglandins are 
implicated in the regulation of cartilage differentiation: 
prostaglandin E 2 stimulates the development of chick limb 
and chondrogenesis [28], and inhibitors of prostaglandin 
synthesis inhibit chondrogenesis in limb cells in vitro [29], 
Mineralization of cartilage adjacent o the growth zone is 
associated with elevated levels of alkaline phosphatase and 
PLA 2 of matrix vesicles in cartilage [30]. These facts 
suggest hat PLA 2 may participate in diverse metabolic 
processes. Further investigations are necessary to elucidate 
the function of group II PLAe in the metabolism of 
intervertebral discs. 
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